Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
EDI048
DRUG
2 trials
Sponsors
Novartis Pharmaceuticals
Conditions
Cryptosporidiosis
Healthy Volunteers
Phase 1
First in Human Study to Assess the Safety, Tolerability and Pharmacokinetics of EDI048 in Healthy Volunteers
Completed
NCT05275855
Novartis Pharmaceuticals
Healthy Volunteers
Start: 2022-04-29
End: 2024-12-18
Updated: 2025-01-10
Phase 2
Study Testing the Efficacy, Safety, and Tolerability of EDI048 in Cryptosporidium Infection Model in Healthy Adults
Recruiting
NCT07249463
Novartis Pharmaceuticals
Cryptosporidiosis
Start: 2025-12-08
End: 2027-03-23
Target: 80
Updated: 2026-08-19